Recent Posts
- EMA publishes detailed guidance on electronic submission of authorized medicines
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 April 2026
- Behind each safe medication, there is a PV expert who analyses, prevents and protects
- EMA’s Data Protection Notice for the exchange of information during the Critical Medicines Vulnerability Assessment exercise
- Social Media and Pharmacovigilance 📱💊
Recent Comments
No comments to show.




